A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs

	A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
	Lu, S.2; Zhang, Y.3; Zhang, G.4; Zhou, J.5; Cang, S.6; Cheng, Y.7; Wu, G.8; Cao, P.9; Lv, D.1; Jian, H.2
刊名	JOURNAL OF THORACIC ONCOLOGY
	2022-09-01
卷号	17
关键词	third-generation EGFR-TKI befotertinib T790M
ISSN号	1556-0864
WOS研究方向	Oncology ; Respiratory System
语种	英语
出版者	ELSEVIER SCIENCE INC
WOS记录号	WOS:000858678101268
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/129941]
专题	中国科学院合肥物质科学研究院
作者单位	1.Taizhou Hosp Zhejiang Prov, Linhai, Peoples R China 2.Shanghai Chest Hosp, Shanghai, Peoples R China 3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 4.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China 5.Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Peoples R China 6.Henan Prov Peoples Hosp, Zhengzhou, Peoples R China 7.Jilin Canc Hosp, Changchun, Peoples R China 8.Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China 9.Cent South Univ, Xiangya Hosp 3, Changsha, Peoples R China 10.Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
推荐引用方式 GB/T 7714	Lu, S.,Zhang, Y.,Zhang, G.,et al. A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17.
APA	Lu, S..,Zhang, Y..,Zhang, G..,Zhou, J..,Cang, S..,...&Zhang, S..(2022).A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs.JOURNAL OF THORACIC ONCOLOGY,17.
MLA	Lu, S.,et al."A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs".JOURNAL OF THORACIC ONCOLOGY 17(2022).